https://charts.traderzeitung.de/phases/US26745T1016 string(1442) "{"isin":"US26745T1016","name":"Dyadic International Inc","stock_id_xnas":8978064,"stock_id_xnys":null,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.405,"close_at":"2026-09-21 21:38:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.403,"close_at":"2026-09-22 21:32:00","complete":true,"perf_pct":-0.4938},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":0.422,"close_at":"2026-09-22 23:57:00","complete":true,"perf_pct":4.7146}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.41,"close_at":"2026-09-23 21:47:00","complete":true,"perf_pct":-2.8436},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":0.423,"close_at":"2026-09-24 00:27:00","complete":false,"perf_pct":3.1707}]}]}"

Dyadic International Aktie News & Nachrichten

[WKN: A0JK0A | Symbol: DYAI]

Realtimekurs

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Dyadic International gefunden werden.

Dyadic International Nachrichtenticker öffnen

MT Newswires 07.07.2026 15:33 Uhr

Dyadic International treibt mehrere Proteinproduktionspartnerschaften voran

09:32 AM EDT, 07/07/2026 (MT Newswires) -- Dyadic International (DYAI) hat in seinen globalen Gesundheitspartnerschaften unter Verwendung seiner C1-Pr

MT Newswires 29.06.2026 14:14 Uhr

Dyadic International erhält japanische Patenterteilung für rekombinante Proteinexpressions-Technologie

08:13 AM EDT, 06/29/2026 (MT Newswires) -- Dyadic International (DYAI) teilte am Montag mit, dass das japanische Patentamt seine Ansprüche zugelassen